Septerna, Inc. (NASDAQ:SEPN – Get Free Report) gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $11.49, but opened at $11.00. Septerna shares last traded at $11.27, with a volume of 71,895 shares.
The company reported ($0.56) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.51). The business had revenue of $0.12 million for the quarter, compared to analyst estimates of $22.50 million. Septerna had a negative return on equity of 31.52% and a negative net margin of 12,053.03%.
Analysts Set New Price Targets
SEPN has been the subject of several recent analyst reports. HC Wainwright initiated coverage on Septerna in a research note on Monday, June 23rd. They set a “buy” rating and a $26.00 target price for the company. Cantor Fitzgerald raised their target price on Septerna from $20.00 to $25.00 and gave the stock an “overweight” rating in a research note on Friday, May 16th. Finally, Wells Fargo & Company raised their target price on Septerna from $11.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 16th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $26.75.
Institutional Investors Weigh In On Septerna
A number of institutional investors have recently modified their holdings of the company. RA Capital Management L.P. acquired a new stake in shares of Septerna in the fourth quarter valued at $160,205,000. TRV GP V LLC acquired a new stake in shares of Septerna in the fourth quarter valued at $142,337,000. BVF Inc. IL grew its stake in shares of Septerna by 79.3% in the first quarter. BVF Inc. IL now owns 4,396,124 shares of the company’s stock valued at $25,454,000 after buying an additional 1,944,100 shares in the last quarter. TRV GP VI LLC grew its stake in shares of Septerna by 33.6% in the first quarter. TRV GP VI LLC now owns 4,211,659 shares of the company’s stock valued at $24,386,000 after buying an additional 1,059,203 shares in the last quarter. Finally, Driehaus Capital Management LLC grew its stake in shares of Septerna by 20.6% in the first quarter. Driehaus Capital Management LLC now owns 3,122,608 shares of the company’s stock valued at $18,080,000 after buying an additional 533,055 shares in the last quarter.
Septerna Stock Performance
The stock has a market capitalization of $520.88 million and a price-to-earnings ratio of -1.16. The company has a 50 day moving average of $11.47 and a 200 day moving average of $9.27.
About Septerna
We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.
Further Reading
- Five stocks we like better than Septerna
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Earnings Reports Give a Snapshot of Consumer Sentiment
- Where Do I Find 52-Week Highs and Lows?
- Amazon’s Bears Have Raised the White Flag—Get Excited
- What Are the FAANG Stocks and Are They Good Investments?
- Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead?
Receive News & Ratings for Septerna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Septerna and related companies with MarketBeat.com's FREE daily email newsletter.
